April 30, 2026
On April 27, the House unanimously passed a bill authorizing trained pharmacists to initiate, prescribe, dispense, and administer buprenorphine for the treatment of opioid use disorder.
Under current law, pharmacists may only prescribe buprenorphine through a collaborative practice agreement (CPA) with a physician. Pharmacist representatives indicate that such agreements have been limited in practice, citing physician concerns related to evolving clinical guidelines and liability.
Supporters of the bill (HF 4493, Baker, R – Willmar) also note that independent prescribing authority offers greater flexibility than a statewide protocol model, allowing pharmacists to more readily align with updated clinical guidance.
The MMA strongly supports this legislation, citing significant unmet demand for opioid use disorder treatment, and the need to expand timely access to care.
Rep. Robert Bierman (DFL – Apple Valley) described the bill as “a life-or-death bill for many people who are seeking substance use disorder treatment and can’t get it in a timely fashion.”
The legislation now moves to the Senate.
July 30, 2026
MMA members are encouraged to vote in Minnesota’s primary election on Tuesday, August 11. The primary election determines which candidates will be on the ballot in the November general election.
July 30, 2026
Early-bird pricing for the MMA’s 2026-2027 Minnesota Physician Leadership Institute (MNPLI) ends Friday, July 31 – take advantage of the $500 savings today.
July 30, 2026
This year, three physicians and one medical student are running for seats in the Minnesota Legislature.